Categories
All News Energy Entertainment Fashion Politics Sports

GET COMPREHENSIVE ANALYSIS OF HOW COVID-19 IS IMPACTING THE NANOTECHNOLOGY IN DRUG DELIVERY MARKET ACCESS PHARMACEUTICALS, CAMURUS, ALKERMES, AQUANOVA, CELGENE, CAPSULUTION PHARMA

Global Nanotechnology in Drug Delivery Market Analysis to 2025 is a specialized and in-depth study of the Nanotechnology in Drug Delivery industry with a focus on the global market trend. The report aims to provide an overview of global Nanotechnology in Drug Delivery Market with detailed market segmentation by product/application and geography. Nanotechnology in Drug Delivery Market report covers the present and past market scenarios, market development patterns, and is likely to proceed with a continuing development over the forecast period.

The global Nanotechnology in Drug Delivery market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 6.8% in the forecast period of 2020 to 2025 and will expected to reach USD 8000.6 million by 2025, from USD 6153.4 million in 2019.

Get Sample Copy of this Report @ https://www.reportsweb.com/inquiry&RW00013335363/sample

Some of the Key Players of Nanotechnology in Drug Delivery Market:

  • Access Pharmaceuticals
  • Camurus
  • Alkermes
  • Aquanova
  • Celgene
  • Capsulution Pharma

The Global Nanotechnology in Drug Delivery Market research report offers an in-depth analysis of the global market, providing relevant information for the new market entrants or well-established players. Some of the key strategies employed by leading key players operating in the market and their impact analysis have been included in this research report.

Market Analysis by

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Nanotechnology in Drug Delivery market based on product and application. It also provides market size and forecast till 2024 for overall Nanotechnology in Drug Delivery market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments.

Get Discount for This Report @ https://www.reportsweb.com/inquiry&RW00013335363/discount

Market segmentation:

By Type, Nanotechnology in Drug Delivery market has been segmented into

  • Targeted Delivery
  • Drug Package

By Application, Nanotechnology in Drug Delivery has been segmented into:

  • Cancer
  • Tumor

The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive analysis for all five regions.

Fundamentals of Table of Content:

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.5 Market by Application
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Nanotechnology in Drug Delivery Market Size
2.2 Nanotechnology in Drug Delivery Growth Trends by Regions
2.3 Industry Trends

3 Market Share by Key Players
3.1 Nanotechnology in Drug Delivery Market Size by Manufacturers
3.2 Nanotechnology in Drug Delivery Key Players Head office and Area Served
3.3 Key Players Nanotechnology in Drug Delivery Product/Solution/Service
3.4 Date of Enter into Nanotechnology in Drug Delivery Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Nanotechnology in Drug Delivery Sales by Product
4.2 Global Nanotechnology in Drug Delivery Revenue by Product
4.3 Nanotechnology in Drug Delivery Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Nanotechnology in Drug Delivery Breakdown Data by End User

Purchase This Report @ https://www.reportsweb.com/buy&RW00013335363/buy/3480

About ReportsWeb:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.

Contact Us:
Call: +1-646-491-9876
Email: [email protected]

Categories
All News Energy Fashion Politics Space Sports

Nanotechnology in Drug Delivery: Market Research Report Explores The Trade Trends For The Forecast 2021 – 2026 | Alkermes, Access Pharmaceuticals, Camurus, Celgene

Nanotechnology in Drug Delivery Market With COVID19-Pandemic Impact Analysis:

Nanotechnology in Drug Delivery Market 2021 this report is including with the COVID19 Outbreak Impact analysis of key points influencing the growth of the market. Also, Nanotechnology in Drug Delivery Market (By major key players, By Types, By Applications, and Leading Regions) Segments outlook, Business assessment, Competition scenario, Trends and Forecast by Upcoming Year’s. The study of the Nanotechnology in Drug Delivery report is done based on the significant research methodology that provides the analytical inspection of the global market based on various segments the Industry is alienated into also the summary and advance size of the marketplace owing to the various outlook possibilities. The report also gives 360-degree overview of the competitive landscape of the industries. SWOT analysis has been used to understand the strength, weaknesses, opportunities, and threats in front of the businesses. Thus, helping the companies to understand the threats and challenges in front of the businesses. Nanotechnology in Drug Delivery market is showing steady growth and CAGR is expected to improve during the forecast period.

GET a FREE Sample Report or PDF Copy NOW!

This Free report sample includes:
  1. A brief introduction to the Nanotechnology in Drug Delivery Market research report.
  2. Graphical introduction of the regional analysis.
  3. Top players in the Nanotechnology in Drug Delivery Market with their revenue analysis.
  4. Selected illustrations of Nanotechnology in Drug Delivery Market insights and trends.
  5. Example pages from the Nanotechnology in Drug Delivery Market report.


enquiry

The Major Players in the Nanotechnology in Drug Delivery Market.

Alkermes
Access Pharmaceuticals
Camurus
Celgene
Capsulution Pharma
Aquanova

Key Businesses Segmentation of Nanotechnology in Drug Delivery Market

on the basis of types, the Nanotechnology in Drug Delivery market from 2015 to 2025 is primarily split into:
Targeted Delivery
Drug Package

on the basis of applications, the Nanotechnology in Drug Delivery market from 2015 to 2025 covers:
Cancer
Tumor
Other

Some of the key factors contributing to the Nanotechnology in Drug Delivery market growth include:

  • Growing per capita disposable income
  • Favorable for youth Demographics
  • Technology advancement

In terms of COVID 19 impact, the Nanotechnology in Drug Delivery market report also includes following data points:

  • Impact on Nanotechnology in Drug Delivery market Size
  • End User Trend, Preferences and Budget Impact of Nanotechnology in Drug Delivery market
  • Regulatory Framework/Government Policies
  • Key Players Strategy to Tackle Negative Impact of Nanotechnology in Drug Delivery market
  • New Opportunity Window of Nanotechnology in Drug Delivery market

Regional Nanotechnology in Drug Delivery Market Analysis:

It could be divided into two different sections: one for regional production analysis and the other for regional consumption analysis. Here, the analysts share gross margin, price, revenue, production, CAGR, and other factors that indicate the growth of all regional markets studied in the report. covering North America, Europe, Asia-Pacific, South America, Middle East, and Africa.

Key Question Answered in Nanotechnology in Drug Delivery Market Report.

  • What are the strengths and weaknesses of the Nanotechnology in Drug Delivery Market?
  • What are the different marketing and distribution channels?
  • What is the current CAGR of the Nanotechnology in Drug Delivery Market?
  • What are the Nanotechnology in Drug Delivery market opportunities in front of the market?
  • What are the highest competitors in Nanotechnology in Drug Delivery market?
  • What are the key outcomes of SWOT and Porter’s five techniques?
  • What is the Nanotechnology in Drug Delivery market size and growth rate in the forecast period?

Purchase FULL Report Now! https://www.qurateresearch.com/report/buy/BnF/2020-2025-global-nanotechnology-in-drug-delivery-market/QBI-MR-BnF-986338

A free report data (as a form of Excel Datasheet) will also be provided upon request along with a new purchase.

Major Points from Table of Contents:

There are 13 Chapters to thoroughly display the Nanotechnology in Drug Delivery market. This report included the analysis of market overview, market characteristics, industry chain, competition landscape, historical and future data by types, applications, and regions.

  • Chapter 1: Nanotechnology in Drug Delivery Market Overview, Product Overview, Market Segmentation, Market Overview of Regions, Market Dynamics, Limitations, Opportunities and Industry News and Policies.
  • Chapter 2: Nanotechnology in Drug Delivery Industry Chain Analysis, Upstream Raw Material Suppliers, Major Players, Production Process Analysis, Cost Analysis, Market Channels, and Major Downstream Buyers.
  • Chapter 3: Value Analysis, Production, Growth Rate and Price Analysis by Type of Nanotechnology in Drug Delivery.
  • Chapter 4: Downstream Characteristics, Consumption and Market Share by Application of Nanotechnology in Drug Delivery.
  • Chapter 5: Production Volume, Price, Gross Margin, and Revenue ($) of Nanotechnology in Drug Delivery by Regions.
  • Chapter 6: Nanotechnology in Drug Delivery Production, Consumption, Export, and Import by Regions.
  • Chapter 7: Nanotechnology in Drug Delivery Market Status and SWOT Analysis by Regions.
  • Chapter 8: Competitive Landscape, Product Introduction, Company Profiles, Market Distribution Status by Players of Nanotechnology in Drug Delivery.
  • Chapter 9: Nanotechnology in Drug Delivery Market Analysis and Forecast by Type and Application.
  • Chapter 10: Nanotechnology in Drug Delivery Market Analysis and Forecast by Regions.
  • Chapter 11: Nanotechnology in Drug Delivery Industry Characteristics, Key Factors, New Entrants SWOT Analysis, Investment Feasibility Analysis.
  • Chapter 12: Nanotechnology in Drug Delivery Market Conclusion of the Whole Report.
  • Chapter 13: Appendix Such as Methodology and Data Resources of Nanotechnology in Drug Delivery Market Research.

(*If you have any special requirements, please let us know and we will offer you the report as you want.)

Note – In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Read More Latest Newsletter

A technological race with China is a matter of concern for the Pentagon’s Acquisition candidate
By 2030 “arrival on the moon” is promised by the President of South Korea – Moon Jae-in
LeoStella – a commercial satellite maker searches for openings in the defense market of the United States
A Georgian media company to apply Azerspace-1 satellite to broadcast local TV channels in a striking deal with Azercosmos
Guangzhou attempts to create a Chinese commercial space cluster like Geely
Contact Us:
Web: www.qurateresearch.com
E-mail: [email protected]
Ph: US – +13393375221, IN – +919881074592

Categories
All News

Nanotechnology in Drug Delivery Market 2021 Is Booming Across the Globe by Share, Size, Growth, Segments and Forecast to 2027 | Top Players Analysis- Access Pharmaceuticals, Alkermes, Aquanova, Camurus, Capsulution Pharma, etc.

DataIntelo has included a latest report on the Global Nanotechnology in Drug Delivery Market into its archive of market research studies. The report is an amalgamation of detailed market overview based on the segmentations, applications, trends and opportunities, mergers and acquisitions, drivers, and restraints. The report showcases the current and forthcoming technical and financial details of the Nanotechnology in Drug Delivery market. The research study attracts attention to a detailed synopsis of the market valuation, revenue estimation, and market statistics. The study on the emerging trends in the global and regional spaces on all the significant components, such as market capacity, cost, price, demand and supply, production, profit, and competitive landscape. The report also explores all the key factors affecting the growth of the global market, consisting of the demand-supply scenario, pricing structure, profit margins, production, and value chain analysis.

Some of the major companies that are covered in this report:

Access Pharmaceuticals
Alkermes
Aquanova
Camurus
Capsulution Pharma
Celgene

*Note: Additional companies can be included on request

Get a free exclusive sample report of Nanotechnology in Drug Delivery market @ https://dataintelo.com/request-sample/?reportId=101591

Impact of COVID-19

The report also talks about the impact of the ongoing global crisis i.e., COVID-19 on the Nanotechnology in Drug Delivery market and explains how the future is going to unfold for the global market. Our analysts have researched thoroughly about the effects of the pandemic on the global economy. The outbreak has directly affected production and demand disrupted the demand and supply chain. The report also computes the financial impact on firms and financial markets. DataIntelo has accumulated insights from several delegates of the industry and got involved in the primary and secondary research to offer the clients data & strategies to combat the market challenges during and after the COVID-19 pandemic.

Highlights of the report:

The published report is made using a vigorous and thorough research methodology and DataIntelo is also known for its data accuracy and granular market reports.
A whole picture of the competitive scenario of the Nanotechnology in Drug Delivery market is illustrated by this report.
The report consists of a vast amount of data about the recent product and technological developments in the markets.
The report also includes deep analysis regarding the impact of these advancements on the future of market growth.
DataIntelo is keeping a track of the market since 2015 and has integrated the necessary historical data & analysis into the research report. Therefore, any additional data requirement can be easily fulfilled.
The insights in the report are easy to understand and include a graphical representation of the numbers in the form of histograms, bar graphs, pie charts, etc.
Components such as market drivers, restraints, challenges, and opportunities for Nanotechnology in Drug Delivery market are elaborated in detail.
It also presents a complete assessment of the anticipated behavior about the future market and continuously transforming market scenario.
Making an informed business decision is a tricky job; this report gives several strategic business methodologies to support you in making those decisions.

Our research analysts who are the building blocks of the company have worked extensively to fabricate the research report which will give that extra edge to our clients’ business in the competitive market. The market research report can be customized as per you and your needs. This means that DataIntelo can cover a particular product, application, or can offer a detailed analysis in the report. You can also buy a separate report for a specific region.

You can buy the complete report in PDF format: @ https://dataintelo.com/checkout/?reportId=101591

The market scenario is likely to be fairly competitive. To analyze any market with simplicity the market is fragmented into the following segments:

By Applications:

Cancer
Tumor
Other

By Types:

Targeted Delivery
Drug Package

By Regions:

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Segmenting the market into smaller components helps in analyzing the dynamics of the market with more clarity. Another key component that is integrated into the report is the regional analysis to assess the global presence of the Nanotechnology in Drug Delivery market. You can also opt for a yearly subscription of all the updates on the Nanotechnology in Drug Delivery market.

If you have any questions on this report, feel free to reach us! @ https://dataintelo.com/enquiry-before-buying/?reportId=101591

Below is the TOC of the report:

Executive Summary

Assumptions and Acronyms Used

Research Methodology

Nanotechnology in Drug Delivery Market Overview

Global Nanotechnology in Drug Delivery Market Analysis and Forecast by Type

Global Nanotechnology in Drug Delivery Market Analysis and Forecast by Application

Global Nanotechnology in Drug Delivery Market Analysis and Forecast by Sales Channel

Global Nanotechnology in Drug Delivery Market Analysis and Forecast by Region

North America Nanotechnology in Drug Delivery Market Analysis and Forecast

Latin America Nanotechnology in Drug Delivery Market Analysis and Forecast

Europe Nanotechnology in Drug Delivery Market Analysis and Forecast

Asia Pacific Nanotechnology in Drug Delivery Market Analysis and Forecast

Asia Pacific Nanotechnology in Drug Delivery Market Size and Volume Forecast by Application

Middle East & Africa Nanotechnology in Drug Delivery Market Analysis and Forecast

Competition Landscape

About DataIntelo:

DataIntelo has a vast experience in making customized market research reports in a number of industry verticals. We strive for complete client satisfaction. We cover in-depth market analysis, which consists of stipulating lucrative business strategies, especially for the new entrants and the emerging players of the market. Our team makes sure that each report goes through intensive primary, secondary research, interviews, and consumer surveys before final dispatch.

We invest in our analysts to ensure that we have a full roster of experience and expertise in any field we cover. Our team members are selected for stellar academic records, specializations in technical fields, and exceptional analytical and communication skills. We also provide ongoing training and knowledge sharing to keep our analysts tapped into industry best practices and loaded with information.

Contact Info:

Name: Alex Mathews

Address: 500 East E Street, Ontario,

CA 91764, United States.

Phone No: USA: +1 909 545 6473

Email:[email protected]

Website:https://dataintelo.com

Categories
World

Nano Drugs in Market by Regional Analysis, Industry Share, Demand, Insights and Global Outlook During 2020-2027

Global Nanotechnology in Drug Delivery Market is expected to reach the market valuation of US$ 182.3 billion by 2027 expanding at a reasonable CAGR of 19.9% during the forecast period (2021-2027) from US$ 44 billion in 2019. Nanotechnology is utilized in targeted drug delivery at the site of disease to expand the uptake of poorly soluble drugs, the targeting of drugs to a precise site, and drug bioavailability.

The various factors driving the Nanotechnology in Drug Delivery market include the increasing necessity for alternative approaches to conventional chemotherapy generates prospects for nanoparticles, the need for developing new and improved drug and gene delivery methods, and increasing prevalence of chronic diseases and illnesses like cancer and cardiovascular diseases. However, the transition from microparticles to nanoparticles leading to problems like interarticular friction and research and development of nanomaterials for drug delivery in large scale production is expected to hinder the growth of the Nanotechnology in Drug Delivery market.

Request for Sample of the report browse through – https://univdatos.com/request_form/form/355

Amid the COVID-19 pandemic, the nanotechnology tools gave great utility across numerous routes ranging from viral neutralization and identification to vaccine production and treatment. While considering that SARS-CoV-2 has nanometric dimensions with a core-shell nanostructure, nanotechnology comes into play and could therefore be considered as an afunctional nanomaterial. Nanocarriers also have the potential to design risk-free and effective immunization strategies for SARS-CoV-2 vaccine candidates such as protein constructs and nucleic acids. A study performed by Leuschner et al. brings a direction in the use of nanotechnology to control the cytokine storm which is amongst few clinical complications of COVID-19.

Based on technology, the market is fragmented into nanoparticles, liposomes, nanocrystals, micelles, and others. The nanoparticles segment dominated the market in 2019 and generated total revenue of US$ 12 billion. It is anticipated to maintain its dominance during the forecast period owing to the easily modified and functionalized surface of nanoparticles which increases the specificity of therapeutic agents in the targeted tissue. However, the micelles segment is expected to witness the highest CAGR growth during the forecast period.

For a detailed analysis of the technology in Nanotechnology in Drug Delivery Market browse through-  https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market:-current-analysis-and-forecast-2020-2027

Nanotechnology in Drug Delivery holds potential in various applications including oncology, cardiovascular/physiology, anti-inflammatory/ immunology, neurology, anti-infective, and others. The oncology segment dominated the market and generated revenue of US$ 15.9 billion in 2019 owing to the increasing number of cancer cases. In 2018, Cancer was amongst the top leading cause of death worldwide, with an estimated 9.6 million deaths, or 1 in 6 deaths.

Browse – mhealth App Market

Additionally, the report provides detailed initiatives that are being taken in the field of Nanotechnology in Drug Delivery. The market is classified into distinct regions North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, Australia, South Korea, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of US$ 18.9 billion in 2019 owing to the increasing prevalence rate of cancer, presence of high disposable income, and rise in funding for R&D activities associated with Nanotechnology in Drug Delivery. Cancer is the leading cause of death in Canada and the second-leading cause, after heart disease, in the USA. Nearly 1.9 million new cancer cases and 693,000 cancer deaths were estimated in North America in 2018.

Browse – Healthcare Chatbots Market

Camarus AB, Nanobiotix, NanoCarrier Co., Ltd., Selecta Biosciences, Starpharma Holdings Limited, Taiwan Liposome Co., Pfizer, Novartis, Merck & Co., and Bayer are some of the prominent players operating in the global Nanotechnology in Drug Delivery market. Several M&A’s along with partnerships have been undertaken by these players to develop Nanotechnology in Drug Delivery.

Global Nanotechnology in Drug Delivery Market Segmentation

Market Insight, by Technology

  • Nanoparticles
  • Liposomes
  • Nanocrystals
  • Micelles
  • Others

Market Insight, by Application

  • Oncology
  • Cardiovascular/ Physiology
  • Anti-inflammatory/ Immunology
  • Neurology
  • Anti-infective
  • Others

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • India
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Camarus AB
  • Taiwan Liposome Co.
  • Novartis
  • Nanobiotix
  • NanoCarrier Co., Ltd.
  • Bayer
  • Selecta Biosciences
  • Pfizer
  • Starpharma Holdings Limited
  • Merck & Co.

The Nanotechnology in Drug Delivery Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Table of Contents

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Nanotechnology in Drug Delivery Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Nanotechnology in Drug Delivery Market
2.1.1 Main Objective of the Global Nanotechnology in Drug Delivery Market
3 INDUSTRY PERFORMANCE
4 EXECUTIVE SUMMARY
5 FEW TOP START-UPS UNDER NANOTECHNOLOGY IN DRUG DELIVERY SECTOR
6 NANOTECHNOLOGY IN DRUG DELIVERY AMID COVID-19
7 GLOBAL NANOTECHNOLOGY IN DRUG DELIVERY MARKET BY REVENUE
8 MARKET INSIGHTS BY TECHNOLOGY
8.1 Nanoparticles
8.2 Liposomes
8.3 Nanocrystals
8.4 Micelles
8.5 Others
9 MARKET INSIGHTS BY APPLICATION
9.1 Oncology
9.2 Cardiovascular/Physiology
9.3 Anti-inflammatory/Immunology
9.4 Neurology
9.5 Anti-infective
9.6 Others
10 MARKET INSIGHTS BY REGION 
10.1 North America Nanotechnology in Drug Delivery Market 
10.1.1 United States
10.1.2 Canada
10.1.3 Rest of North America
10.2 Europe Nanotechnology in Drug Delivery Market 
10.2.1 Germany
10.2.2 France
10.2.3 United Kingdom
10.2.4 Italy
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia-Pacific Nanotechnology in Drug Delivery Market
10.3.1 China
10.3.2 Japan
10.3.3 South Korea
10.3.4 Australia
10.3.5 India
10.3.6 Rest of Asia Pacific
10.4 Rest of the World Nanotechnology in Drug Delivery Market 
11 NANOTECHNOLOGY IN DRUG DELIVERY MARKET DYNAMICS
11.1 Market Drivers
11.2 Market Challenges
11.3 Impact Analysis
12 LEGAL & REGULATORY FRAMEWORK
13 DEMAND AND SUPPLY SIDE ANALYSIS
13.1 Demand Side Analysis
13.2 Supply Side Analysis
13.2.1 Top Product Launches
13.2.2 Top Business Partnerships
13.2.3 Top Merger & Acquisitions
14 VALUE CHAIN ANALYSIS
15 NANOTECHNOLOGY IN DRUG DELIVERY MARKET OPPORTUNITIES
16 NANOTECHNOLOGY IN DRUG DELIVERY MARKET TRENDS 
17 COMPETITIVE SCENARIO
17.1 Porter’s Five Forces Analysis
17.1.1 Bargaining power of Supplier
17.1.2 Bargaining power of Buyer
17.1.3 Industry Rivalry
17.1.4 Availability of Substitute
17.1.5 Threat of new Entrants
17.2 Competitive Landscape
17.2.1 Company Shares, By Revenue
18 COMPANY PROFILED
18.1 Camarus AB
18.1.1 Key Facts
18.1.2 Ownership Structure
18.1.3 Business Description
18.1.4 Key Product/Services Offerings
18.1.5 Growth Strategy
18.1.6 SWOT Analysis
18.1.7 Key Financials
18.1.7.1 Revenue Split
18.1.7.2 Financial Overview of Camarus AB
18.1.8 Recent Developments
18.1.8.1 Product Launches
18.2 Taiwan Liposome Co
18.3 Novartis
18.4 Nanobiotix
18.5 NanoCarrier Co, LTD
18.6 Bayer
18.7 Selecta Biosciences
18.8 Pfizer
18.9 Starpharma Holdings Limited
18.10 Merck & Co
19 DISCLAIMER

About Us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

Contact us:

UnivDatos Market Insights (UMI)

Email: [email protected]

Web: https://univdatos.com

Ph: +91 7838604911

Categories
World

Nanotechnology in Drug Delivery Market Report Examines Analysis by Latest Trends, Growth Factors, Key Players and 2027

Emphasis on Technology (Nanoparticles, Liposomes, Nanocrystals, Micelles, Others), Application (Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Neurology, Anti-infective, Others), and Region/Country

Nanotechnology provides superior drug delivery systems for better control and treatment of diseases by manipulating the properties of materials such as polymers and creating nanostructures. There are various advantages to the nanostructures employed as drug delivery systems that make them advanced to conventional delivery systems. Nanoparticles have emerged as key players in modern medicine in recent years, with applications ranging from contrast agents in medical imaging to gene delivery carriers in individual cells. Researchers are working on the utilization of nanoparticles to make drugs even more effective by having an in-depth understanding of the interaction of nanoparticles with cells, and the optimal toxicity or concentration. In this sector, healthcare R&D is seeing increased expenditure on nanosized materials and devices.

To avail Sample Copy of report, visit @ https://univdatos.com/request_form/form/355

A developing number of nanotherapeutic drugs have been commercialized or reached the clinical stage in recent years. Compared to traditional drugs, enhanced pharmacokinetics, biocompatibility, tumor targeting, and stability are associated with NP-based drug delivery systems, while simultaneously playing an important role in minimizing systemic toxicity and overcoming drug resistance. For oncology applications, over 20% of the therapeutic nanoparticles already in clinics or under clinical evaluation have been created. Most FDA-approved therapeutic nanoparticles are currently being designed for the re-formulation of combinations of chemotherapeutic drugs with polymeric nanoparticles. According to the WHO, CVDs kill 17.9 million people per year, an estimated 31% of all deaths worldwide. For the treatment of cardiovascular diseases, the use of nanoparticle-based formulations is primarily focused on targeted delivery and increasing bioavailability for vascular restenosis. Up to 23.5 million Americans (more than 7% of the population) suffer from an autoimmune disease, according to the National Institutes of Health, and the numbers are increasing. The rising prevalence of cancer and chronic diseases remain among the primary influences driving this surge.

Camarus AB, Nanobiotix, NanoCarrier Co., Ltd., Selecta Biosciences, Starpharma Holdings Limited, Taiwan Liposome Co., Pfizer, Novartis, Merck & Co., and Bayer are some of the prominent players operating in the global Nanotechnology in Drug Delivery market. Several M&A’s along with partnerships have been undertaken by these players to facilitate customers with hi-tech and innovative products.

Examine Detailed Index of full Research Study at @ https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market-current-analysis-and-forecast-2020-2027

Insights Presented in the Report

“Amongst technology, nanoparticles segment holds the major share”

Based on the technology type, the market is fragmented into nanoparticles, liposomes, nanocrystals, micelles, and others. The nanoparticles segment dominated the market with a share of 27.2% in 2019 and is expected to maintain its dominance during the forecast period owing to the better biocompatibility, non-immunogenicity, non-toxicity, and biodegradability compared to conventional approaches.

“Amongst application, oncology is anticipated to dominate the market during the analyzed period”

Further based on application, the market is mainly bifurcated into oncology, cardiovascular/physiology, anti-inflammatory/ immunology, neurology, anti-infective, and others. In 2019, oncology accounted for a maximum market revenue share of 36% and is expected to remain dominant during the analyzed period owing to the increasing development of nano-drug delivery in the oncology due to the advantages of nanoparticle (NP)-based drug delivery systems in cancer treatment, such as good pharmacokinetics, precise targeting of tumor cells, reduction of side effects, and drug resistance. However, the anti-inflammatory/ immunology segment is anticipated to grow at the highest CAGR over the forecast period.

“North America signifies one of the largest markets of Nanotechnology in Drug Delivery Market

For a better understanding of the market dynamics of the Nanotechnology in Drug Delivery market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, Australia, South Korea, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of US$ 18.9 billion in 2019 owing to the increasing prevalence rate of cancer, presence of high disposable income, and rise in funding for R&D activities associated with Nanotechnology in Drug Delivery. For instance, Cancer is the leading cause of death in Canada and the second-leading cause, after heart disease, in the USA. Nearly 1.9 million new cancer cases and 693,000 cancer deaths were estimated in North America in 2018.

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The Nanotechnology in Drug Delivery Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

UnivDatos Market Insights (UMI) Latest Research Report –

About Us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

Contact us:

UnivDatos Market Insights (UMI)

Email: [email protected]

Web: https://univdatos.com

Ph: +91 7838604911

Categories
World

Nano Drugs in Market Research Report (Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020-2027)

Global Nanotechnology in Drug Delivery Market is expected to reach the market valuation of US$ 182.3 billion by 2027 expanding at a reasonable CAGR of 19.9% during the forecast period (2021-2027) from US$ 44 billion in 2019. Nanotechnology is utilized in targeted drug delivery at the site of disease to expand the uptake of poorly soluble drugs, the targeting of drugs to a precise site, and drug bioavailability.

The various factors driving the Nanotechnology in Drug Delivery market include the increasing necessity for alternative approaches to conventional chemotherapy generates prospects for nanoparticles, the need for developing new and improved drug and gene delivery methods, and increasing prevalence of chronic diseases and illnesses like cancer and cardiovascular diseases. However, the transition from microparticles to nanoparticles leading to problems like interarticular friction and research and development of nanomaterials for drug delivery in large scale production is expected to hinder the growth of the Nanotechnology in Drug Delivery market.

Request for Sample of the report browse through – https://univdatos.com/request_form/form/355

Amid the COVID-19 pandemic, the nanotechnology tools gave great utility across numerous routes ranging from viral neutralization and identification to vaccine production and treatment. While considering that SARS-CoV-2 has nanometric dimensions with a core-shell nanostructure, nanotechnology comes into play and could therefore be considered as an afunctional nanomaterial. Nanocarriers also have the potential to design risk-free and effective immunization strategies for SARS-CoV-2 vaccine candidates such as protein constructs and nucleic acids. A study performed by Leuschner et al. brings a direction in the use of nanotechnology to control the cytokine storm which is amongst few clinical complications of COVID-19.

Based on technology, the market is fragmented into nanoparticles, liposomes, nanocrystals, micelles, and others. The nanoparticles segment dominated the market in 2019 and generated total revenue of US$ 12 billion. It is anticipated to maintain its dominance during the forecast period owing to the easily modified and functionalized surface of nanoparticles which increases the specificity of therapeutic agents in the targeted tissue. However, the micelles segment is expected to witness the highest CAGR growth during the forecast period.

For a detailed analysis of the technology in Nanotechnology in Drug Delivery Market browse through-  https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market:-current-analysis-and-forecast-2020-2027

Nanotechnology in Drug Delivery holds potential in various applications including oncology, cardiovascular/physiology, anti-inflammatory/ immunology, neurology, anti-infective, and others. The oncology segment dominated the market and generated revenue of US$ 15.9 billion in 2019 owing to the increasing number of cancer cases. In 2018, Cancer was amongst the top leading cause of death worldwide, with an estimated 9.6 million deaths, or 1 in 6 deaths.

Browse – mhealth App Market

Additionally, the report provides detailed initiatives that are being taken in the field of Nanotechnology in Drug Delivery. The market is classified into distinct regions North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, Australia, South Korea, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of US$ 18.9 billion in 2019 owing to the increasing prevalence rate of cancer, presence of high disposable income, and rise in funding for R&D activities associated with Nanotechnology in Drug Delivery. Cancer is the leading cause of death in Canada and the second-leading cause, after heart disease, in the USA. Nearly 1.9 million new cancer cases and 693,000 cancer deaths were estimated in North America in 2018.

Browse – Healthcare Chatbots Market

Camarus AB, Nanobiotix, NanoCarrier Co., Ltd., Selecta Biosciences, Starpharma Holdings Limited, Taiwan Liposome Co., Pfizer, Novartis, Merck & Co., and Bayer are some of the prominent players operating in the global Nanotechnology in Drug Delivery market. Several M&A’s along with partnerships have been undertaken by these players to develop Nanotechnology in Drug Delivery.

Global Nanotechnology in Drug Delivery Market Segmentation

Market Insight, by Technology

  • Nanoparticles
  • Liposomes
  • Nanocrystals
  • Micelles
  • Others

Market Insight, by Application

  • Oncology
  • Cardiovascular/ Physiology
  • Anti-inflammatory/ Immunology
  • Neurology
  • Anti-infective
  • Others

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • India
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Camarus AB
  • Taiwan Liposome Co.
  • Novartis
  • Nanobiotix
  • NanoCarrier Co., Ltd.
  • Bayer
  • Selecta Biosciences
  • Pfizer
  • Starpharma Holdings Limited
  • Merck & Co.

The Nanotechnology in Drug Delivery Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Table of Contents

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Nanotechnology in Drug Delivery Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Nanotechnology in Drug Delivery Market
2.1.1 Main Objective of the Global Nanotechnology in Drug Delivery Market
3 INDUSTRY PERFORMANCE
4 EXECUTIVE SUMMARY
5 FEW TOP START-UPS UNDER NANOTECHNOLOGY IN DRUG DELIVERY SECTOR
6 NANOTECHNOLOGY IN DRUG DELIVERY AMID COVID-19
7 GLOBAL NANOTECHNOLOGY IN DRUG DELIVERY MARKET BY REVENUE
8 MARKET INSIGHTS BY TECHNOLOGY
8.1 Nanoparticles
8.2 Liposomes
8.3 Nanocrystals
8.4 Micelles
8.5 Others
9 MARKET INSIGHTS BY APPLICATION
9.1 Oncology
9.2 Cardiovascular/Physiology
9.3 Anti-inflammatory/Immunology
9.4 Neurology
9.5 Anti-infective
9.6 Others
10 MARKET INSIGHTS BY REGION 
10.1 North America Nanotechnology in Drug Delivery Market 
10.1.1 United States
10.1.2 Canada
10.1.3 Rest of North America
10.2 Europe Nanotechnology in Drug Delivery Market 
10.2.1 Germany
10.2.2 France
10.2.3 United Kingdom
10.2.4 Italy
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia-Pacific Nanotechnology in Drug Delivery Market
10.3.1 China
10.3.2 Japan
10.3.3 South Korea
10.3.4 Australia
10.3.5 India
10.3.6 Rest of Asia Pacific
10.4 Rest of the World Nanotechnology in Drug Delivery Market 
11 NANOTECHNOLOGY IN DRUG DELIVERY MARKET DYNAMICS
11.1 Market Drivers
11.2 Market Challenges
11.3 Impact Analysis
12 LEGAL & REGULATORY FRAMEWORK
13 DEMAND AND SUPPLY SIDE ANALYSIS
13.1 Demand Side Analysis
13.2 Supply Side Analysis
13.2.1 Top Product Launches
13.2.2 Top Business Partnerships
13.2.3 Top Merger & Acquisitions
14 VALUE CHAIN ANALYSIS
15 NANOTECHNOLOGY IN DRUG DELIVERY MARKET OPPORTUNITIES
16 NANOTECHNOLOGY IN DRUG DELIVERY MARKET TRENDS 
17 COMPETITIVE SCENARIO
17.1 Porter’s Five Forces Analysis
17.1.1 Bargaining power of Supplier
17.1.2 Bargaining power of Buyer
17.1.3 Industry Rivalry
17.1.4 Availability of Substitute
17.1.5 Threat of new Entrants
17.2 Competitive Landscape
17.2.1 Company Shares, By Revenue
18 COMPANY PROFILED
18.1 Camarus AB
18.1.1 Key Facts
18.1.2 Ownership Structure
18.1.3 Business Description
18.1.4 Key Product/Services Offerings
18.1.5 Growth Strategy
18.1.6 SWOT Analysis
18.1.7 Key Financials
18.1.7.1 Revenue Split
18.1.7.2 Financial Overview of Camarus AB
18.1.8 Recent Developments
18.1.8.1 Product Launches
18.2 Taiwan Liposome Co
18.3 Novartis
18.4 Nanobiotix
18.5 NanoCarrier Co, LTD
18.6 Bayer
18.7 Selecta Biosciences
18.8 Pfizer
18.9 Starpharma Holdings Limited
18.10 Merck & Co
19 DISCLAIMER

About Us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

Contact us:

UnivDatos Market Insights (UMI)

Email: [email protected]

Web: https://univdatos.com

Ph: +91 7838604911

Categories
All News

Global Nanotechnology in Drug Delivery Market 2020 In-depth Research Studies on Products, Countries, Companies and Industry Segmentation by 2025

Nanotechnology for Drug Delivery Applications

Prepared in collaboration with the leading industry experts, the report titled Global Nanotechnology in Drug Delivery Market 2020 by Company, Regions, Type and Application, Forecast to 2025 gives data on different manufacturers, regions, and products which are important to understanding the market. The report provides a complete market scope and growth rate throughout the past present and forecast period 2020-2025. With a concise study, the report highlights in-depth market insights related to the global Nanotechnology in Drug Delivery market. The study effectively describes the market value, volume, price trend, and growth opportunities. All prominent players are assessed with their company profile, product portfolio, market share, and revenue. Additionally, the barriers and risk factors are included in this study.

The report sheds light on current market trends, opportunities, challenges, and detailed competitive analysis of the industry players in the market. It also highlights potential headway openings that prevail in the global market. Detailed analysis of market status, enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends, regional industrial layout characteristics, and macroeconomic policies, as well as raw materials, end-users of this industry are given in the report.

NOTE: Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE REPORT: https://www.marketsandresearch.biz/sample-request/121692

Market Segmentation:

The segmentation of the market is as follows – distribution channel, product type, region, and application. Both developed and emerging regions are deeply studied by the authors of the report. Product type refers to the different variants available in the report. When it comes to application, it deals with end-users, who are responsible for generating demand for the product/service. The regional analysis section of the report offers a comprehensive analysis of the global Nanotechnology in Drug Delivery market on the basis of region.

List of top key players in the market report are: Access Pharmaceuticals, Camurus, Alkermes, Aquanova, Celgene, Capsulution Pharma

On the basis of product, this report displays the production, revenue, price, market share, and growth rate of each type, primarily split into: Targeted Delivery, Drug Package

On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including: Cancer, Tumor, Other

Regional segment analysis displaying regional production volume, consumption volume, revenue, and growth rate from 2020-2025 covers: North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, etc.), Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

ACCESS FULL REPORT: https://www.marketsandresearch.biz/report/121692/global-nanotechnology-in-drug-delivery-market-2020-by-company-regions-type-and-application-forecast-to-2025

Elaborating On the Competitive Landscape of the Industry Market:

  • The study delivers crucial insights pertaining to the production patterns of the manufactured items, the revenue generated as well as the company profile among others.
  • The report also highlights the global Nanotechnology in Drug Delivery market share that each firm holds and their respective gross margins.
  • Furthermore, a business overview, revenue share, and SWOT analysis of the leading players in the market are available in the report

Customization of the Report:

This report can be customized to meet the client’s requirements. Please connect with our sales team ([email protected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Marketsandresearch.biz is a leading global Market Research agency providing expert research solutions, trusted by the best. We understand the importance of knowing what global consumers watch and buy, further using the same to document our distinguished research reports. Marketsandresearch.biz has worldwide presence to facilitate real market intelligence using latest methodology, best-in-class research techniques and cost-effective measures for world’s leading research professionals and agencies. We study consumers in more than 100 countries to give you the most complete view of trends and habits worldwide. Marketsandresearch.biz is a leading provider of Full-Service Research, Global Project Management, Market Research Operations and Online Panel Services.

Contact Us
Mark Stone
Head of Business Development
Phone: +1-201-465-4211
Email: [email protected]
Web: www.marketsandresearch.biz

Categories
World

Nanotechnology Drug Delivery Market (2020-2027) | Emphasis on Technology (Nanoparticles, Liposomes, Nanocrystals, Micelles, Others)

Global Nanotechnology in Drug Delivery Market is expected to reach the market valuation of US$ 182.3 billion by 2027 expanding at a reasonable CAGR of 19.9% during the forecast period (2021-2027) from US$ 44 billion in 2019. Nanotechnology is utilized in targeted drug delivery at the site of disease to expand the uptake of poorly soluble drugs, the targeting of drugs to a precise site, and drug bioavailability.

The various factors driving the Nanotechnology in Drug Delivery market include the increasing necessity for alternative approaches to conventional chemotherapy generates prospects for nanoparticles, the need for developing new and improved drug and gene delivery methods, and increasing prevalence of chronic diseases and illnesses like cancer and cardiovascular diseases. However, the transition from microparticles to nanoparticles leading to problems like interarticular friction and research and development of nanomaterials for drug delivery in large scale production is expected to hinder the growth of the Nanotechnology in Drug Delivery market.

Request for Sample of the report browse through – https://univdatos.com/request_form/form/355

Amid the COVID-19 pandemic, the nanotechnology tools gave great utility across numerous routes ranging from viral neutralization and identification to vaccine production and treatment. While considering that SARS-CoV-2 has nanometric dimensions with a core-shell nanostructure, nanotechnology comes into play and could therefore be considered as an afunctional nanomaterial. Nanocarriers also have the potential to design risk-free and effective immunization strategies for SARS-CoV-2 vaccine candidates such as protein constructs and nucleic acids. A study performed by Leuschner et al. brings a direction in the use of nanotechnology to control the cytokine storm which is amongst few clinical complications of COVID-19.

Based on technology, the market is fragmented into nanoparticles, liposomes, nanocrystals, micelles, and others. The nanoparticles segment dominated the market in 2019 and generated total revenue of US$ 12 billion. It is anticipated to maintain its dominance during the forecast period owing to the easily modified and functionalized surface of nanoparticles which increases the specificity of therapeutic agents in the targeted tissue. However, the micelles segment is expected to witness the highest CAGR growth during the forecast period.

For a detailed analysis of the technology in Nanotechnology in Drug Delivery Market browse through-  https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market:-current-analysis-and-forecast-2020-2027

Nanotechnology in Drug Delivery holds potential in various applications including oncology, cardiovascular/physiology, anti-inflammatory/ immunology, neurology, anti-infective, and others. The oncology segment dominated the market and generated revenue of US$ 15.9 billion in 2019 owing to the increasing number of cancer cases. In 2018, Cancer was amongst the top leading cause of death worldwide, with an estimated 9.6 million deaths, or 1 in 6 deaths.

Browse – mhealth App Market

Additionally, the report provides detailed initiatives that are being taken in the field of Nanotechnology in Drug Delivery. The market is classified into distinct regions North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, Australia, South Korea, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of US$ 18.9 billion in 2019 owing to the increasing prevalence rate of cancer, presence of high disposable income, and rise in funding for R&D activities associated with Nanotechnology in Drug Delivery. Cancer is the leading cause of death in Canada and the second-leading cause, after heart disease, in the USA. Nearly 1.9 million new cancer cases and 693,000 cancer deaths were estimated in North America in 2018.

Browse – Healthcare Chatbots Market

Camarus AB, Nanobiotix, NanoCarrier Co., Ltd., Selecta Biosciences, Starpharma Holdings Limited, Taiwan Liposome Co., Pfizer, Novartis, Merck & Co., and Bayer are some of the prominent players operating in the global Nanotechnology in Drug Delivery market. Several M&A’s along with partnerships have been undertaken by these players to develop Nanotechnology in Drug Delivery.

Global Nanotechnology in Drug Delivery Market Segmentation

Market Insight, by Technology

  • Nanoparticles
  • Liposomes
  • Nanocrystals
  • Micelles
  • Others

Market Insight, by Application

  • Oncology
  • Cardiovascular/ Physiology
  • Anti-inflammatory/ Immunology
  • Neurology
  • Anti-infective
  • Others

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • India
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Camarus AB
  • Taiwan Liposome Co.
  • Novartis
  • Nanobiotix
  • NanoCarrier Co., Ltd.
  • Bayer
  • Selecta Biosciences
  • Pfizer
  • Starpharma Holdings Limited
  • Merck & Co.

The Nanotechnology in Drug Delivery Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Table of Contents

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Nanotechnology in Drug Delivery Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Nanotechnology in Drug Delivery Market
2.1.1 Main Objective of the Global Nanotechnology in Drug Delivery Market
3 INDUSTRY PERFORMANCE
4 EXECUTIVE SUMMARY
5 FEW TOP START-UPS UNDER NANOTECHNOLOGY IN DRUG DELIVERY SECTOR
6 NANOTECHNOLOGY IN DRUG DELIVERY AMID COVID-19
7 GLOBAL NANOTECHNOLOGY IN DRUG DELIVERY MARKET BY REVENUE
8 MARKET INSIGHTS BY TECHNOLOGY
8.1 Nanoparticles
8.2 Liposomes
8.3 Nanocrystals
8.4 Micelles
8.5 Others
9 MARKET INSIGHTS BY APPLICATION
9.1 Oncology
9.2 Cardiovascular/Physiology
9.3 Anti-inflammatory/Immunology
9.4 Neurology
9.5 Anti-infective
9.6 Others
10 MARKET INSIGHTS BY REGION 
10.1 North America Nanotechnology in Drug Delivery Market 
10.1.1 United States
10.1.2 Canada
10.1.3 Rest of North America
10.2 Europe Nanotechnology in Drug Delivery Market 
10.2.1 Germany
10.2.2 France
10.2.3 United Kingdom
10.2.4 Italy
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia-Pacific Nanotechnology in Drug Delivery Market
10.3.1 China
10.3.2 Japan
10.3.3 South Korea
10.3.4 Australia
10.3.5 India
10.3.6 Rest of Asia Pacific
10.4 Rest of the World Nanotechnology in Drug Delivery Market 
11 NANOTECHNOLOGY IN DRUG DELIVERY MARKET DYNAMICS
11.1 Market Drivers
11.2 Market Challenges
11.3 Impact Analysis
12 LEGAL & REGULATORY FRAMEWORK
13 DEMAND AND SUPPLY SIDE ANALYSIS
13.1 Demand Side Analysis
13.2 Supply Side Analysis
13.2.1 Top Product Launches
13.2.2 Top Business Partnerships
13.2.3 Top Merger & Acquisitions
14 VALUE CHAIN ANALYSIS
15 NANOTECHNOLOGY IN DRUG DELIVERY MARKET OPPORTUNITIES
16 NANOTECHNOLOGY IN DRUG DELIVERY MARKET TRENDS 
17 COMPETITIVE SCENARIO
17.1 Porter’s Five Forces Analysis
17.1.1 Bargaining power of Supplier
17.1.2 Bargaining power of Buyer
17.1.3 Industry Rivalry
17.1.4 Availability of Substitute
17.1.5 Threat of new Entrants
17.2 Competitive Landscape
17.2.1 Company Shares, By Revenue
18 COMPANY PROFILED
18.1 Camarus AB
18.1.1 Key Facts
18.1.2 Ownership Structure
18.1.3 Business Description
18.1.4 Key Product/Services Offerings
18.1.5 Growth Strategy
18.1.6 SWOT Analysis
18.1.7 Key Financials
18.1.7.1 Revenue Split
18.1.7.2 Financial Overview of Camarus AB
18.1.8 Recent Developments
18.1.8.1 Product Launches
18.2 Taiwan Liposome Co
18.3 Novartis
18.4 Nanobiotix
18.5 NanoCarrier Co, LTD
18.6 Bayer
18.7 Selecta Biosciences
18.8 Pfizer
18.9 Starpharma Holdings Limited
18.10 Merck & Co
19 DISCLAIMER

About Us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

Contact us:

UnivDatos Market Insights (UMI)

Email: [email protected]

Web: https://univdatos.com

Ph: +91 7838604911

Categories
World

Nanotechnology in Drug Delivery Market: Industry Analysis and Upcoming Trends (2020-2027) Emphasis on Technology (Nanoparticles, Liposomes, Nanocrystals, Micelles, Others)

Nanotechnology provides superior drug delivery systems for better control and treatment of diseases by manipulating the properties of materials such as polymers and creating nanostructures. There are various advantages to the nanostructures employed as drug delivery systems that make them advanced to conventional delivery systems. Nanoparticles have emerged as key players in modern medicine in recent years, with applications ranging from contrast agents in medical imaging to gene delivery carriers in individual cells. Researchers are working on the utilization of nanoparticles to make drugs even more effective by having an in-depth understanding of the interaction of nanoparticles with cells, and the optimal toxicity or concentration. In this sector, healthcare R&D is seeing increased expenditure on nanosized materials and devices.

To avail Sample Copy of report, visit @ https://univdatos.com/request_form/form/355

A developing number of nanotherapeutic drugs have been commercialized or reached the clinical stage in recent years. Compared to traditional drugs, enhanced pharmacokinetics, biocompatibility, tumor targeting, and stability are associated with NP-based drug delivery systems, while simultaneously playing an important role in minimizing systemic toxicity and overcoming drug resistance. For oncology applications, over 20% of the therapeutic nanoparticles already in clinics or under clinical evaluation have been created. Most FDA-approved therapeutic nanoparticles are currently being designed for the re-formulation of combinations of chemotherapeutic drugs with polymeric nanoparticles. According to the WHO, CVDs kill 17.9 million people per year, an estimated 31% of all deaths worldwide. For the treatment of cardiovascular diseases, the use of nanoparticle-based formulations is primarily focused on targeted delivery and increasing bioavailability for vascular restenosis. Up to 23.5 million Americans (more than 7% of the population) suffer from an autoimmune disease, according to the National Institutes of Health, and the numbers are increasing. The rising prevalence of cancer and chronic diseases remain among the primary influences driving this surge.

Timeline of the development of Nanomedicine

Camarus AB, Nanobiotix, NanoCarrier Co., Ltd., Selecta Biosciences, Starpharma Holdings Limited, Taiwan Liposome Co., Pfizer, Novartis, Merck & Co., and Bayer are some of the prominent players operating in the global Nanotechnology in Drug Delivery market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.

For a detailed analysis of the market drivers in Nanotechnology in Drug Delivery Market browse through https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market:-current-analysis-and-forecast-2020-2027

Insights Presented in the Report

Amongst technology, nanoparticles segment holds the major share”

Based on the technology type, the market is fragmented into nanoparticles, liposomes, nanocrystals, micelles, and others. The nanoparticles segment dominated the market with a share of 27.2% in 2019 and is expected to maintain its dominance during the forecast period owing to the better biocompatibility, non-immunogenicity, non-toxicity, and biodegradability compared to conventional approaches.

Browse – Global Healthcare Chatbots Market: Current Analysis and Forecast (2020-2027)

“Amongst application, oncology is anticipated to dominate the market during the analyzed period”

Further based on application, the market is mainly bifurcated into oncology, cardiovascular/physiology, anti-inflammatory/ immunology, neurology, anti-infective, and others. In 2019, oncology accounted for a maximum market revenue share of 36% and is expected to remain dominant during the analyzed period owing to the increasing development of nano-drug delivery in the oncology due to the advantages of nanoparticle (NP)-based drug delivery systems in cancer treatment, such as good pharmacokinetics, precise targeting of tumor cells, reduction of side effects, and drug resistance. However, the anti-inflammatory/ immunology segment is anticipated to grow at the highest CAGR over the forecast period.

“North America signifies one of the largest markets of Nanotechnology in Drug Delivery Market”

For a better understanding of the market dynamics of the Nanotechnology in Drug Delivery market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, Australia, South Korea, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of US$ 18.9 billion in 2019 owing to the increasing prevalence rate of cancer, presence of high disposable income, and rise in funding for R&D activities associated with Nanotechnology in Drug Delivery. For instance, Cancer is the leading cause of death in Canada and the second-leading cause, after heart disease, in the USA. Nearly 1.9 million new cancer cases and 693,000 cancer deaths were estimated in North America in 2018.

Feel free to contact us for any queries @ https://univdatos.com/contact-us

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts
  • The report presents a quick review of overall industry performance at one glance
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
  • The study comprehensively covers the market across different segments
  • Deep dive regional level analysis of the industry

Customization Options:

The Nanotechnology in Drug Delivery Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Table of Contents

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Nanotechnology in Drug Delivery Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Nanotechnology in Drug Delivery Market
2.1.1 Main Objective of the Global Nanotechnology in Drug Delivery Market
3 INDUSTRY PERFORMANCE
4 EXECUTIVE SUMMARY
5 FEW TOP START-UPS UNDER NANOTECHNOLOGY IN DRUG DELIVERY SECTOR
6 NANOTECHNOLOGY IN DRUG DELIVERY AMID COVID-19
7 GLOBAL NANOTECHNOLOGY IN DRUG DELIVERY MARKET BY REVENUE
8 MARKET INSIGHTS BY TECHNOLOGY
8.1 Nanoparticles
8.2 Liposomes
8.3 Nanocrystals
8.4 Micelles
8.5 Others
9 MARKET INSIGHTS BY APPLICATION
9.1 Oncology
9.2 Cardiovascular/Physiology
9.3 Anti-inflammatory/Immunology
9.4 Neurology
9.5 Anti-infective
9.6 Others
10 MARKET INSIGHTS BY REGION 
10.1 North America Nanotechnology in Drug Delivery Market 
10.1.1 United States
10.1.2 Canada
10.1.3 Rest of North America
10.2 Europe Nanotechnology in Drug Delivery Market 
10.2.1 Germany
10.2.2 France
10.2.3 United Kingdom
10.2.4 Italy
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia-Pacific Nanotechnology in Drug Delivery Market
10.3.1 China
10.3.2 Japan
10.3.3 South Korea
10.3.4 Australia
10.3.5 India
10.3.6 Rest of Asia Pacific
10.4 Rest of the World Nanotechnology in Drug Delivery Market 
11 NANOTECHNOLOGY IN DRUG DELIVERY MARKET DYNAMICS
11.1 Market Drivers
11.2 Market Challenges
11.3 Impact Analysis
12 LEGAL & REGULATORY FRAMEWORK
13 DEMAND AND SUPPLY SIDE ANALYSIS
13.1 Demand Side Analysis
13.2 Supply Side Analysis
13.2.1 Top Product Launches
13.2.2 Top Business Partnerships
13.2.3 Top Merger & Acquisitions
14 VALUE CHAIN ANALYSIS
15 NANOTECHNOLOGY IN DRUG DELIVERY MARKET OPPORTUNITIES
16 NANOTECHNOLOGY IN DRUG DELIVERY MARKET TRENDS 
17 COMPETITIVE SCENARIO
17.1 Porter’s Five Forces Analysis
17.1.1 Bargaining power of Supplier
17.1.2 Bargaining power of Buyer
17.1.3 Industry Rivalry
17.1.4 Availability of Substitute
17.1.5 Threat of new Entrants
17.2 Competitive Landscape
17.2.1 Company Shares, By Revenue
18 COMPANY PROFILED
18.1 Camarus AB
18.1.1 Key Facts
18.1.2 Ownership Structure
18.1.3 Business Description
18.1.4 Key Product/Services Offerings
18.1.5 Growth Strategy
18.1.6 SWOT Analysis
18.1.7 Key Financials
18.1.7.1 Revenue Split
18.1.7.2 Financial Overview of Camarus AB
18.1.8 Recent Developments
18.1.8.1 Product Launches
18.2 Taiwan Liposome Co
18.3 Novartis
18.4 Nanobiotix
18.5 NanoCarrier Co, LTD
18.6 Bayer
18.7 Selecta Biosciences
18.8 Pfizer
18.9 Starpharma Holdings Limited
18.10 Merck & Co
19 DISCLAIMER

About Us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

Contact us:

UnivDatos Market Insights (UMI)

Email: [email protected]

Web: https://univdatos.com

Ph: +91 7838604911

Categories
World

Nanotechnology Drug Delivery Market – Industry Analysis and Upcoming Trends (2021-2027)

Global Nanotechnology in Drug Delivery Market is expected to reach the market valuation of US$ 182.3 billion by 2027 expanding at a reasonable CAGR of 19.9% during the forecast period (2021-2027) from US$ 44 billion in 2019. Nanotechnology is utilized in targeted drug delivery at the site of disease to expand the uptake of poorly soluble drugs, the targeting of drugs to a precise site, and drug bioavailability.

The various factors driving the Nanotechnology in Drug Delivery market include the increasing necessity for alternative approaches to conventional chemotherapy generates prospects for nanoparticles, the need for developing new and improved drug and gene delivery methods, and increasing prevalence of chronic diseases and illnesses like cancer and cardiovascular diseases. However, the transition from microparticles to nanoparticles leading to problems like interarticular friction and research and development of nanomaterials for drug delivery in large scale production is expected to hinder the growth of the Nanotechnology in Drug Delivery market.

Request for Sample of the report browse through – https://univdatos.com/request_form/form/355

Amid the COVID-19 pandemic, the nanotechnology tools gave great utility across numerous routes ranging from viral neutralization and identification to vaccine production and treatment. While considering that SARS-CoV-2 has nanometric dimensions with a core-shell nanostructure, nanotechnology comes into play and could therefore be considered as an afunctional nanomaterial. Nanocarriers also have the potential to design risk-free and effective immunization strategies for SARS-CoV-2 vaccine candidates such as protein constructs and nucleic acids. A study performed by Leuschner et al. brings a direction in the use of nanotechnology to control the cytokine storm which is amongst few clinical complications of COVID-19.

Based on technology, the market is fragmented into nanoparticles, liposomes, nanocrystals, micelles, and others. The nanoparticles segment dominated the market in 2019 and generated total revenue of US$ 12 billion. It is anticipated to maintain its dominance during the forecast period owing to the easily modified and functionalized surface of nanoparticles which increases the specificity of therapeutic agents in the targeted tissue. However, the micelles segment is expected to witness the highest CAGR growth during the forecast period.

For a detailed analysis of the technology in Nanotechnology in Drug Delivery Market browse through-  https://univdatos.com/report/global-nanotechnology-in-drug-delivery-market:-current-analysis-and-forecast-2020-2027

Nanotechnology in Drug Delivery holds potential in various applications including oncology, cardiovascular/physiology, anti-inflammatory/ immunology, neurology, anti-infective, and others. The oncology segment dominated the market and generated revenue of US$ 15.9 billion in 2019 owing to the increasing number of cancer cases. In 2018, Cancer was amongst the top leading cause of death worldwide, with an estimated 9.6 million deaths, or 1 in 6 deaths.

Browse – mhealth App Market

Additionally, the report provides detailed initiatives that are being taken in the field of Nanotechnology in Drug Delivery. The market is classified into distinct regions North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, Australia, South Korea, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of US$ 18.9 billion in 2019 owing to the increasing prevalence rate of cancer, presence of high disposable income, and rise in funding for R&D activities associated with Nanotechnology in Drug Delivery. Cancer is the leading cause of death in Canada and the second-leading cause, after heart disease, in the USA. Nearly 1.9 million new cancer cases and 693,000 cancer deaths were estimated in North America in 2018.

Browse – Healthcare Chatbots Market

Camarus AB, Nanobiotix, NanoCarrier Co., Ltd., Selecta Biosciences, Starpharma Holdings Limited, Taiwan Liposome Co., Pfizer, Novartis, Merck & Co., and Bayer are some of the prominent players operating in the global Nanotechnology in Drug Delivery market. Several M&A’s along with partnerships have been undertaken by these players to develop Nanotechnology in Drug Delivery.

Global Nanotechnology in Drug Delivery Market Segmentation

Market Insight, by Technology

  • Nanoparticles
  • Liposomes
  • Nanocrystals
  • Micelles
  • Others

Market Insight, by Application

  • Oncology
  • Cardiovascular/ Physiology
  • Anti-inflammatory/ Immunology
  • Neurology
  • Anti-infective
  • Others

Market Insight, by Region

  • North America
    • United States
    • Canada
    • Rest of North America
  • Europe
    • France
    • Germany
    • Italy
    • Spain
    • United Kingdom
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Australia
    • South Korea
    • India
    • Rest of Asia-Pacific
  • Rest of World

Top Company Profiles

  • Camarus AB
  • Taiwan Liposome Co.
  • Novartis
  • Nanobiotix
  • NanoCarrier Co., Ltd.
  • Bayer
  • Selecta Biosciences
  • Pfizer
  • Starpharma Holdings Limited
  • Merck & Co.

The Nanotechnology in Drug Delivery Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

Table of Contents

1 MARKET INTRODUCTION
1.1 Market Definitions
1.2 Objective of the Study
1.3 Limitation
1.4 Stake Holders
1.5 Currency Used in Report
1.6 Scope of the Global Nanotechnology in Drug Delivery Market Study
2 RESEARCH METHODOLOGY OR ASSUMPTION
2.1 Research Methodology for the Global Nanotechnology in Drug Delivery Market
2.1.1 Main Objective of the Global Nanotechnology in Drug Delivery Market
3 INDUSTRY PERFORMANCE
4 EXECUTIVE SUMMARY
5 FEW TOP START-UPS UNDER NANOTECHNOLOGY IN DRUG DELIVERY SECTOR
6 NANOTECHNOLOGY IN DRUG DELIVERY AMID COVID-19
7 GLOBAL NANOTECHNOLOGY IN DRUG DELIVERY MARKET BY REVENUE
8 MARKET INSIGHTS BY TECHNOLOGY
8.1 Nanoparticles
8.2 Liposomes
8.3 Nanocrystals
8.4 Micelles
8.5 Others
9 MARKET INSIGHTS BY APPLICATION
9.1 Oncology
9.2 Cardiovascular/Physiology
9.3 Anti-inflammatory/Immunology
9.4 Neurology
9.5 Anti-infective
9.6 Others
10 MARKET INSIGHTS BY REGION 
10.1 North America Nanotechnology in Drug Delivery Market 
10.1.1 United States
10.1.2 Canada
10.1.3 Rest of North America
10.2 Europe Nanotechnology in Drug Delivery Market 
10.2.1 Germany
10.2.2 France
10.2.3 United Kingdom
10.2.4 Italy
10.2.5 Spain
10.2.6 Rest of Europe
10.3 Asia-Pacific Nanotechnology in Drug Delivery Market
10.3.1 China
10.3.2 Japan
10.3.3 South Korea
10.3.4 Australia
10.3.5 India
10.3.6 Rest of Asia Pacific
10.4 Rest of the World Nanotechnology in Drug Delivery Market 
11 NANOTECHNOLOGY IN DRUG DELIVERY MARKET DYNAMICS
11.1 Market Drivers
11.2 Market Challenges
11.3 Impact Analysis
12 LEGAL & REGULATORY FRAMEWORK
13 DEMAND AND SUPPLY SIDE ANALYSIS
13.1 Demand Side Analysis
13.2 Supply Side Analysis
13.2.1 Top Product Launches
13.2.2 Top Business Partnerships
13.2.3 Top Merger & Acquisitions
14 VALUE CHAIN ANALYSIS
15 NANOTECHNOLOGY IN DRUG DELIVERY MARKET OPPORTUNITIES
16 NANOTECHNOLOGY IN DRUG DELIVERY MARKET TRENDS 
17 COMPETITIVE SCENARIO
17.1 Porter’s Five Forces Analysis
17.1.1 Bargaining power of Supplier
17.1.2 Bargaining power of Buyer
17.1.3 Industry Rivalry
17.1.4 Availability of Substitute
17.1.5 Threat of new Entrants
17.2 Competitive Landscape
17.2.1 Company Shares, By Revenue
18 COMPANY PROFILED
18.1 Camarus AB
18.1.1 Key Facts
18.1.2 Ownership Structure
18.1.3 Business Description
18.1.4 Key Product/Services Offerings
18.1.5 Growth Strategy
18.1.6 SWOT Analysis
18.1.7 Key Financials
18.1.7.1 Revenue Split
18.1.7.2 Financial Overview of Camarus AB
18.1.8 Recent Developments
18.1.8.1 Product Launches
18.2 Taiwan Liposome Co
18.3 Novartis
18.4 Nanobiotix
18.5 NanoCarrier Co, LTD
18.6 Bayer
18.7 Selecta Biosciences
18.8 Pfizer
18.9 Starpharma Holdings Limited
18.10 Merck & Co
19 DISCLAIMER

About Us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

Contact us:

UnivDatos Market Insights (UMI)

Email: [email protected]

Web: https://univdatos.com

Ph: +91 7838604911